Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among  < 5 year-olds and 15–24 year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Knol, Mirjam J, Ruijs, Wilhelmina LM, Antonise-Kamp, Laura, de Melker, Hester E, van der Ende, Arie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915972/
https://www.ncbi.nlm.nih.gov/pubmed/29692317
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158
_version_ 1783316948321304576
author Knol, Mirjam J
Ruijs, Wilhelmina LM
Antonise-Kamp, Laura
de Melker, Hester E
van der Ende, Arie
author_facet Knol, Mirjam J
Ruijs, Wilhelmina LM
Antonise-Kamp, Laura
de Melker, Hester E
van der Ende, Arie
author_sort Knol, Mirjam J
collection PubMed
description The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among  < 5 year-olds and 15–24 year-olds. The case fatality rate was 12% (17/138) in 2015–2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13–14 year-olds are offered MenACWY vaccination.
format Online
Article
Text
id pubmed-5915972
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-59159722018-05-04 Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018 Knol, Mirjam J Ruijs, Wilhelmina LM Antonise-Kamp, Laura de Melker, Hester E van der Ende, Arie Euro Surveill Rapid Communication The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among  < 5 year-olds and 15–24 year-olds. The case fatality rate was 12% (17/138) in 2015–2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13–14 year-olds are offered MenACWY vaccination. European Centre for Disease Prevention and Control (ECDC) 2018-04-19 /pmc/articles/PMC5915972/ /pubmed/29692317 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158 Text en This article is copyright of The Authors, 2018. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Knol, Mirjam J
Ruijs, Wilhelmina LM
Antonise-Kamp, Laura
de Melker, Hester E
van der Ende, Arie
Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title_full Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title_fullStr Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title_full_unstemmed Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title_short Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
title_sort implementation of menacwy vaccination because of ongoing increase in serogroup w invasive meningococcal disease, the netherlands, 2018
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915972/
https://www.ncbi.nlm.nih.gov/pubmed/29692317
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158
work_keys_str_mv AT knolmirjamj implementationofmenacwyvaccinationbecauseofongoingincreaseinserogroupwinvasivemeningococcaldiseasethenetherlands2018
AT ruijswilhelminalm implementationofmenacwyvaccinationbecauseofongoingincreaseinserogroupwinvasivemeningococcaldiseasethenetherlands2018
AT antonisekamplaura implementationofmenacwyvaccinationbecauseofongoingincreaseinserogroupwinvasivemeningococcaldiseasethenetherlands2018
AT demelkerhestere implementationofmenacwyvaccinationbecauseofongoingincreaseinserogroupwinvasivemeningococcaldiseasethenetherlands2018
AT vanderendearie implementationofmenacwyvaccinationbecauseofongoingincreaseinserogroupwinvasivemeningococcaldiseasethenetherlands2018

Ejemplares similares